Search our team
- Life Sciences
Kevin Johnson is a Partner at Index Ventures working out of the London office.
Prior to that he was CEO of PanGenetics, an antibody development company based in the Netherlands, and one of the Index Ventures portfolio.
Kevin was one of the team at Cambridge Antibody Technology (CAT), heading up research from 1994 onwards. In 1997 he was appointed to the Board, where he held the posts of Research Director and Chief Technology Officer.
Kevin led both the development of CAT's platform technologies, and also their application to the discovery of a number of human antibodies currently in clinical development. Two of these are now marketed, Humira (Abbott Pharmaceutical) and Benlysta (HGS, GSK). He was also part of the management team that floated CAT on the London Stock Exchange (main market).
Kevin graduated in Molecular Biology from Edinburgh University and has a PhD in Pathology from Cambridge University.
Skype is a global P2P telephony company that is changing voice communications by moving voice calling to the Internet. Acquired by eBay in October 2005.
- Danny Rimer, Saul Klein, Mike Volpi
- Communications, Consumer
- Early stage
- Sep 12 2005
- eBay to Acquire Skype
- Mar 15 2004
- SKYPE Closes 'B' Round Funding from Top Venture Capitalists